Sales & Marketing News | pharmaphorum

News

Takeda's long-serving chief executive Christophe Weber has said he will retire next year, after 12 years at the Japanese drugmaker.

News

Genetic testing specialist 23andMe has launched a strategic review that could result in a sale of the company.

News

Novo Nordisk's Ozempic has become the first drug in the GLP-1 class to be cleared to prevent worsening kidney disease in type 2 diabetics.

News

The EMA has abandoned X for Bluesky, saying Elon Musk's social media platform "no longer suits our communication needs."

News

Lyfegen and EVERSANA have joined forces to help pharma companies navigate an increasingly complex global drug pricing and access environment.

News

Regulators have started reviews of GSK's depemokimab, aiming to become the first drug for asthma that can be dosed twice a year.